The Impact of Dual Use of E-Cigarette and Smoking

Jan.27.2025
The Impact of Dual Use of E-Cigarette and Smoking
A recent study from London University reveals a rise in dual smoking and e-cigarette use, especially among young adults.

Recently, a study published on the official website of the University of London, originally published in the journal "Addiction," funded by the British Cancer Research Society, examined survey data from 2016 to 2024.


A study has found that during this period, the proportion of people who both smoke and use e-cigarettes has increased from 3.5% (approximately 1 in 30 people) to 5.2% (approximately 1 in 20 people). This proportion has sharply risen since disposable e-cigarettes first became popular in 2021.


Among young people, the growth is most significant, with nearly two-thirds of smokers aged 18 to 24 also using e-cigarettes by 2024, compared to just one-fifth in 2016.


The research team also found a clear trend among dual users, where there was a shift from more frequent smoking to more frequent use of e-cigarettes. The proportion of daily smokers who did not use e-cigarettes daily decreased from 32% to 15%, while the proportion of daily e-cigarette users who did not smoke daily increased from 8% to 22%, more than doubling.


Researchers say this could be due to an increase in dual use among young people, who tend to use e-cigarettes more frequently than older adults but smoke less frequently. Dr. Sarah Jackson, the lead author of the study from the Institute of Epidemiology and Healthcare at University College London, stated, "Dual use of e-cigarettes and cigarettes is often a transitional phase for people attempting to quit smoking or reduce their smoking. Therefore, if this helps people stay away from smoking in the long term, it may not necessarily be detrimental to their health.


In our study, we found that dual users are transitioning from smoking more frequently to using e-cigarettes more frequently. This could be good news, as dual users can potentially reduce their health risks by increasing their use of e-cigarettes and decreasing smoking.


However, it is important for people to completely quit smoking in order to obtain the full health benefits. For this study, researchers used data from the Smoking Toolkit Study, which is a continuous survey that interviews a representative sample of adults in England each month. They looked at data from 128,588 adults (aged 18 and older) in England from 2016 to 2024.


A research team has found that dual users who mistakenly believe that e-cigarettes are as harmful or even more harmful than traditional cigarettes use e-cigarettes less frequently each day. Researchers say this is significant because daily e-cigarette use is associated with successfully quitting smoking, while non-daily use is not. Therefore, misconceptions about the harm of e-cigarettes may hinder these dual users from reducing or quitting smoking.


Nearly half of dual users (44%) mistakenly believe that e-cigarettes are as harmful or more harmful than traditional cigarettes. Professor Jamie Brown from the University College London Institute of Epidemiology and Health Care stated: "It is important to accurately convey information on the relative harms of smoking and using e-cigarettes so that people can make informed decisions about the products they use. Mass media campaigns should play a key role in this. Government investment in advertising is crucial for achieving the potential of a smoke-free generation policy.


Alice Froggatt, Policy Manager at Cancer Research UK, stated: "In the UK, tobacco is responsible for around 160 cancer cases every day. If you smoke, the best thing you can do for your health is to quit completely.


A study has shown that legal e-cigarettes are much less harmful than tobacco and can help people quit smoking permanently. While it is important for them to be convenient for those trying to quit smoking, they should not fall into the hands of children or be used by those who have never smoked before. In order to help end cancer caused by tobacco, the government must provide continuous funding for cessation services.


Although the proportion of people using e-cigarettes daily and those who do not smoke every day has increased recently, the most common dual-use pattern remains smoking and daily e-cigarette use. This pattern is expected to account for 45% of dual users by 2024. It is more prevalent among older individuals, those of lower socioeconomic status, and those who primarily smoke hand-rolled cigarettes and have a stronger desire to smoke.


The study found that non-daily smoking and daily e-cigarette use are more common among those who have been using e-cigarettes for over a year. Researchers suggest that this discovery is consistent with the possibility that using e-cigarettes may support individuals in transitioning from smoking, even without being in a formal smoking cessation attempt. The UK National Health Service (NHS) advises that using e-cigarettes can help people quit smoking, and while the risks of using e-cigarettes are smaller than smoking, non-smokers should not use e-cigarettes.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello said legal tobacco sales in the country have fallen by more than half over the past decade, with sales declining more than 20% in 2025 compared with the previous year. She warned that the decline may not fully reflect lower smoking rates, as increased availability of illicit cigarettes could also be contributing. The government said it would continue strengthening tobacco and vape retail enforcement while monitoring the impact of illicit tobacco on public health and tax revenue.
Aug.26
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives